Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines
Ficheros
Compartir
Estadísticas
Ver Estadísticas de usoMetadatos
Mostrar el registro completo del ítemAutor/es
Mestorino, Nora; Marchetti, Maria Laura; Lucas, Maria Florencia; Modamio, Pilar; Zeinsteger, Pedro; [et al.]Fecha
2016-06-23Disciplina/s
FarmaciaMedicina
Materia/s
BioequivalencePharmacokinetics
Oxytetracycline
Bovine
Resumen
The aim of this study was to evaluate the bioequivalence of two commercial long-acting formulations based on oxytetracycline (OTC) hydrochloride between the reference formulation (Terramycin LA, Pfizer) and a test formulation (Cyamicin LA, Fort Dodge Saude Animal). Both formulations were administered in a single intramuscular route at a dose of 20 mg OTC/kg of body weight in clinically healthy bovines. The study was carried out according to a one-period parallel design. Plasma samples were analyzed by high-pressure liquid chromatography. The limit of quantitation was 0.050 μg/mL with an accuracy of 101.67% with a coefficient of variation of 13.15%. Analysis of variance and 90% confidence interval tests were used to compare the bioavailability parameters (maximum plasma concentration, Cmax, and the area under the concentration-versus-time curve extrapolated to infinity, AUC0–∞) of both products. In the case of the time to maximum concentration (Tmax), non-parametric tests based on Wilco...